Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA Inc.
1:10-cv-00805
Overview
Parties
Defendant
Teva Pharmaceuticals USA Inc. Operating Company
Represented By
10 Attorneys ListedPhillips, Goldman & Spence, P.A.
Phillips, Goldman & Spence, P.A., 1200 North Broom Street
Phillips, Goldman & Spence, P.A.
Phillips, Goldman & Spence, P.A., 1200 North Broom Street
Teva Pharmaceutical Industries Ltd. Operating Company
Represented By
2 Attorneys ListedPhillips, Goldman & Spence, P.A.
Phillips, Goldman & Spence, P.A., 1200 North Broom Street
Phillips, Goldman & Spence, P.A.
Phillips, Goldman & Spence, P.A., 1200 North Broom Street
Bristol-Myers Squibb Company NPE (Individual / Inventor)
Represented By
7 Attorneys ListedBarnes & Thornburg LLP
1000 N. West Street, Suite 1500, Wilmington, DE 19801
Novak Druce Connolly Bove + Quigg LLP
The Nemours Building, 1007 North Orange Street
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5206244
Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
|
Filed: 1991-09-20
Issued: 1993-04-27
|
Expired (Term Ended)
+1250d PTA
Expires: 2015-02-21
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
High PTA (+1250 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
12
Dispositive
2
Granted
1
Denied
0
Pending / Review
11
Motions by Category
Key Dispositive Motions & Rulings